Equillium Inc. , a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory disorders, today ...
At 11:15 a.m. Pacific, the network carrier T-Mobile suddenly experienced a massive outage with reports spiking over 13,000 in ...
Research shows mitochondria form distinct subpopulations under nutrient stress, revealing survival mechanisms in cancer cells ...
Scientists uncovered a previously unrecognized tumor suppression mechanism through the study of condensates and ribosome formation.
CNW/ - GSK announced today that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or ...
Research and Development (R&D) Expenses: R&D expenses were $16.0 million for the three months ended September 30, 2024, as compared to $14.0 million for the same period in 2023. The increase was ...